Skip to main content
Clinical Trials/NCT04084639
NCT04084639CompletedNot Applicable

To Determine the Effects of Mycoprotein Consumption on Glucose Absorption in Healthy Participants

University of Exeter1 site in 1 country15 target enrollmentStarted: August 28, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
15
Locations
1
Primary Endpoint
Glucose absorption

Study Overview

Brief Summary

Previous research has demonstrated that the food found in Quorn 'Mycoprotein' can lower the blood glucose response to a meal, which may be an important finding for the management of type 2 diabetes. However, it has never been investigated how this lower response occurs, and whether there is dose-dependent response with mycoprotein. The present study will include 12 healthy young adults, who will visit the laboratory for 3 test days, with each day lasting 9 hours. On each visit, separated by a washout period of at least 2 weeks, participants will ingest either a control drink with no mycoprotein, a drink containing 20g mycoprotein or a drink containing 40g mycoprotein. By intravenously infusing labelled glucose during each visit in combination with repeated blood sampling, investigators will determine if the lower blood glucose after mycoprotein ingestion is due to reduced glucose absorption from the gut or increased uptake into body tissues.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Double (Participant, Investigator)

Masking Description

Double blind crossover design

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Male and female
  • 18-35 years of age
  • Consumption of sufficient amounts of carbohydrate in the diet
  • Body mass index between 18.5 and 30

Exclusion Criteria

  • Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes), or other form of abnormal glucose metabolism (as this will affect outcome of the study).
  • Any diagnosed cardiovascular disease
  • Insufficient consumption of carbohydrate in the diet
  • A personal or family history of epilepsy, seizures or schizophrenia
  • Known pre-existing liver disease/condition
  • Allergy or intolerance to milk

Outcomes

Primary Outcomes

Glucose absorption

Time Frame: 6 hours following ingestion of drink

How glucose is absorbed following the ingestion of a mycoprotein drink compared to a placebo control measured using the infusion of stable isotopes

Secondary Outcomes

  • Insulinaemic Response(6 hours following ingestion of drink)
  • Production of Short-Chain Fatty Acids(6 hours following ingestion of drink)
  • Incretin Hormones(6 hours following ingestion of drink)
  • Glucose Kinetics(6 hours following ingestion of drink)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Mycoprotein Consumption and Glucose... | Clinical Trial